1st Quarter - Report

PODESTA GROUP, INC. for EMD SERONO INC

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

S. 877, Controlling the Abuse of Prescriptions Act of 2007 Drug importation H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H. R. 5629, Pathway for Biosimilars Act S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 623, Access to Life-Saving Medicine Act, follow-on biologics

LobbyistCovered position, as disclosed
PAUL BRATHWAITE Exec. Dir., Congressional Black Caucus
SHARON COHEN —
COURTNEY HAGEN —
ANDREW KAUDERS Sr. Adv. Sen. Menendez; ED, House Demo Caucus
ANTHONY PODESTA —
ANNE MARIE POLAK Leg. Correspondent for Rep. Mike Ferguson

Contacted: Patent & Trademark Office (PTO); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA)

Bills named: S. 877 (110th), S. 1505 (110th), H.R. 1038 (110th), H.R. 5629 (110th), S. 2029 (110th), S. 623 (110th), H.R. 1956 (110th), S. 1695 (110th)

Copyright/Patent/Trademark CPT

S. 1145, Patent Reform Act of 2007, entire bill H. R. 1908, Patent Reform Act of 2007, entire bill

LobbyistCovered position, as disclosed
SHARON COHEN —
COURTNEY HAGEN —
CLAUDIA JAMES —
ANTHONY PODESTA —
ANNE MARIE POLAK Leg. Correspondent for Rep. Mike Ferguson

Contacted: Executive Office of the President (EOP); SENATE; Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: S. 1145 (110th), H.R. 1908 (110th)

Budget/Appropriations BUD

LHHS Appropriations Drug importation House Concurrent Resolution 312 House Budget Resolution Senate Concurrent Resolution 70 Senate Budget Resolution Comparative Effectiveness

LobbyistCovered position, as disclosed
SHARON COHEN —
RANDALL GERARD —
ANTHONY PODESTA —
ANNE MARIE POLAK Leg. Correspondent for Rep. Mike Ferguson

Contacted: Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Medicare/Medicaid MMM

H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H. R. 3162, Children's Health and Medicare Protection Act of 2007 H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H. R. 5480, Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Pathway for Biosimilars Act S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provisions Comparative Effectiveness 2008 Medicare Bill

LobbyistCovered position, as disclosed
SHARON COHEN —
ANTHONY PODESTA —
ANNE MARIE POLAK Leg. Correspondent for Rep. Mike Ferguson

Contacted: Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Patent & Trademark Office (PTO); SENATE

Bills named: S. 2662 (110th), S. 2029 (110th), H.R. 4 (110th), H.R. 3162 (110th), H.R. 2606 (110th), S. 1376 (110th), S. 3 (110th), H.R. 5480 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.